A detailed history of Brewin Dolphin Wealth Management LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 20,530 shares of BMY stock, worth $1.14 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
20,530
Previous 20,530 -0.0%
Holding current value
$1.14 Million
Previous $1.5 Million 5.47%
% of portfolio
0.17%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022

SELL
$61.48 - $73.72 $24,592 - $29,488
-400 Reduced 1.91%
20,530 $1.5 Million
Q4 2021

Nov 14, 2022

BUY
$53.63 - $62.52 $1.12 Million - $1.31 Million
20,930 New
20,930 $1.31 Million
Q2 2021

Nov 09, 2023

BUY
$61.91 - $67.42 $85,745 - $93,376
1,385 Added 6.33%
23,250 $1.55 Billion
Q1 2021

Nov 09, 2023

SELL
$59.34 - $66.74 $16,911 - $19,020
-285 Reduced 1.29%
21,865 $1.38 Billion
Q4 2020

Nov 09, 2023

SELL
$57.74 - $65.43 $6,640 - $7,524
-115 Reduced 0.52%
22,150 $1.37 Billion
Q2 2020

Nov 09, 2023

BUY
$54.82 - $64.09 $95,112 - $111,196
1,735 Added 8.45%
22,265 $1.31 Billion
Q1 2020

Nov 09, 2023

SELL
$46.4 - $67.43 $32,480 - $47,201
-700 Reduced 3.52%
19,200 $1.07 Billion
Q4 2019

Nov 09, 2023

SELL
$49.21 - $64.19 $380,393 - $496,188
-7,730 Reduced 27.98%
19,900 $1.28 Billion
Q3 2019

Nov 09, 2023

SELL
$42.77 - $50.71 $21,385 - $25,355
-500 Reduced 1.78%
27,630 $1.4 Billion
Q2 2019

Nov 09, 2023

BUY
$44.62 - $49.34 $139,660 - $154,434
3,130 Added 12.52%
28,130 $1.28 Billion
Q1 2019

Nov 09, 2023

BUY
$45.12 - $53.8 $201,686 - $240,486
4,470 Added 21.77%
25,000 $1.19 Billion
Q3 2018

Nov 09, 2023

SELL
$55.19 - $62.25 $65,124 - $73,455
-1,180 Reduced 5.75%
19,350 $1.2 Billion
Q2 2018

Nov 09, 2023

BUY
$50.53 - $62.98 $70,742 - $88,172
1,400 Added 7.8%
19,350 $1.07 Billion
Q3 2017

Nov 09, 2023

SELL
$55.23 - $63.74 $142,493 - $164,449
-2,580
17,950 $1.14 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Brewin Dolphin Wealth Management LTD Portfolio

Follow Brewin Dolphin Wealth Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin Wealth Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin Wealth Management LTD with notifications on news.